Back to Search Start Over

Kidney and contrast media: Common viewpoint of the French Nephrology societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelines.

Authors :
de Laforcade L
Bobot M
Bellin MF
Clément O
Grangé S
Grenier N
Wynckel A
Guerrot D
Source :
Diagnostic and interventional imaging [Diagn Interv Imaging] 2021 Mar; Vol. 102 (3), pp. 131-139. Date of Electronic Publication: 2021 Jan 30.
Publication Year :
2021

Abstract

Contrast medium administration is classically considered to cause or worsen kidney failure, but recent data may moderate this assertion. The European Society of Urogenital Radiology recently published guidelines re-evaluating the precautions before administering contrast media. Kidney injury does not constitute a contra-indication to the administration of iodinated contrast medium, as long as the benefit-risk ratio justifies it. Intravenous hydration with 0.9% NaCl or 1.4% sodium bicarbonate is the only validated measure for the prevention of post-iodine contrast nephropathy. This is necessary for intravenous or intra-arterial administration of iodinated contrast agent without first renal pass when the glomerular filtration rate is less than 30mL/min/1.73m <superscript>2</superscript> , for intra-arterial administration of iodinated contrast agent with first renal passage when the glomerular filtration rate is less than 45mL/min/1.73m <superscript>2</superscript> , or in patients with acute renal failure. The use of iodinated contrast medium should allow the carrying out of relevant examinations based on an analysis of the benefit-risk ratio and the implementation of measures to prevent toxicity when necessary.<br /> (Copyright © 2021 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.)

Details

Language :
English
ISSN :
2211-5684
Volume :
102
Issue :
3
Database :
MEDLINE
Journal :
Diagnostic and interventional imaging
Publication Type :
Academic Journal
Accession number :
33531265
Full Text :
https://doi.org/10.1016/j.diii.2021.01.007